China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback 
Google Secures Pentagon AI Deal for Classified Projects 
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case 
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector 
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal 
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth 
NEW YORK, Feb. 17, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of investors who purchased Nobilis Health Corp. (NYSE:HLTH) securities between April 2, 2015 and January 6, 2016.
Click here to learn about the case: http://docs.wongesq.com/HLTH-Info-Request-Form-951. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Nobilis’ financial statements contained numerous errors concerning the classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results; (2) Nobilis overstated its net income for the year ended December 31, 2014 by more than $4 million; (3) Nobilis overstated its net income for the quarter ended March 31, 2015 by more than $3.27 million; and (4) as a result, defendants’ statements about Nobilis’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
If you suffered a loss in Nobilis Health you have until March 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/HLTH-Info-Request-Form-951.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
